Teladoc Health, Inc. (TDOC) Q2 2025 Earnings Call Transcript
Teladoc Health, Inc. Q2 2025 Earnings Conference Call July 29, 2025 4:30 PM ET Company Participants Charles Divita - CEO & Director Mala Murthy - Chief Financial Officer Michael Minchak - Vice President of Investor Relations Conference Call Participants Sarah Elizabeth James - Cantor Fitzgerald & Co., Research Division Charles Rhyee - TD Cowen, Research Division Daniel R. Grosslight - Citigroup Inc., Research Division David Harrison Roman - Goldman Sachs Group, Inc., Research Division Elizabeth Hammell Anderson - Evercore ISI Institutional Equities, Research Division Jailendra P.
Teladoc (TDOC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Teladoc (TDOC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Teladoc (TDOC) Reports Q2 Loss, Beats Revenue Estimates
Teladoc (TDOC) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.28 per share a year ago.
Teladoc (TDOC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teladoc Health: A Beaten-Down Bargain Worth A Second Look (Upgrade)
I've upgraded Teladoc to a tepid buy—not a full conviction call, but the numbers finally tilt in its favor. I believe the company's innovative platform positions it as a leader in digital healthcare, driving long-term value. 7x forward free cash flow is just too low to ignore, even with weak top-line growth.
Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Teladoc (TDOC) concluded the recent trading session at $8.58, signifying a -1.49% move from its prior day's close.
Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last?
Teladoc (TDOC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Teladoc (TDOC) Rises Higher Than Market: Key Facts
In the most recent trading session, Teladoc (TDOC) closed at $7.02, indicating a +2.33% shift from the previous trading day.
Teladoc Health, Inc. (TDOC) Presents at Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)
Teladoc Health, Inc. (NYSE:TDOC ) Goldman Sachs 46th Annual Global Healthcare Conference June 11, 2025 11:30 AM ET Company Participants Charles Divita - CEO & Director Mala Murthy - Chief Financial Officer Conference Call Participants David Harrison Roman - Goldman Sachs Group, Inc., Research Division David Harrison Roman Very pleased to welcome the management team from Teladoc, Chuck Divita, Chief Executive Officer; and Mala Murthy, Chief Financial Officer. Very much appreciate you taking the time to participate in the conference and look forward to getting an update on Teladoc here.
Teladoc (TDOC) Outperforms Broader Market: What You Need to Know
In the closing of the recent trading day, Teladoc (TDOC) stood at $7.40, denoting a +1.79% change from the preceding trading day.
Why Is Teladoc (TDOC) Down 0.1% Since Last Earnings Report?
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?
TDOC Q1 Loss Narrower Than Estimates on Strong Integrated Care Unit
Teladoc Health expects Integrated Care members to be between 101 million and 103 million in 2025.
